Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TROICA: Tenecteplase in Cardiac Arrest
NCT00157261Phase 3Terminated
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2004
- Primary completion
- Jun 2006
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 9
01
Overview
A Phase 3 trial of tenecteplase in cardiac arrest (SCA), sponsored by Boehringer Ingelheim. Started Jan 2004; status: terminated.
02
Drugs
tenecteplase
03
Conditions
cardiac arrest (SCA)
Beyond the preview
Go deeper on NCT00157261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00157261.